CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | September/October 2015

Alternative Access and Closure Options for TAVR

Transaortic, subclavian, or axillary access can be reasonable in TAVR patients who are not candidates for the transfemoral approach.

By Colin Barker, MD, and Michael J. Reardon, MD

cit | Article | September/October 2015

Optimal Access/Reliable Closure

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | September 2008

Sirolimus-Eluting Cypher Stent

A standard of comparison for drug-eluting stents.

By Colin M. Barker, MD, and David E. Kandzari, MD

Sponsored by Funding for this supplement provided by Medtronic

cit | Article | July/August 2018 Supplement

Are TAVR Hemodynamics Important in the Lower-Risk Population?

How the hemodynamic effects of TAVR and SAVR impact clinical outcomes.

By Colin M. Barker, MD; Moritz Wyler von Ballmoos, MD; and Michael J. Reardon, MD

Advertisement

Advertisement

cit | News | May 20, 2022

Alleviant’s No-Implant Interatrial Shunt Device to Treat Heart Failure Patients Evaluated in Multicenter Clinical Data

May 20, 2022—The Society for Cardiovascular Angiography & Interventions (SCAI) announced that results from early clinical evaluation of the Alleviant system (Alleviant Medical, Inc.) for the treatment of heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) demonstrated procedural safety and feasibility, with a promising efficacy signal through 6 months.

cit | Article | January/February 2022

Atrial Septal Defects and Patent Foramen Ovale: Current Data Update

Primary clinical manifestations associated with PFO and ASD and their therapeutic implications.

By Marilena Di Salvo, MD; Marco Monte, MD; and Marco Barbanti, MD

cit | Article | March/April 2020

TAVR for Bicuspid Aortic Valve Disease

A look at the next frontier.

By Hussein Rahim, MD; Mariusz Wolbinski, MD; Vinayak Bapat, MBBS; and Tamim M. Nazif, MD

cit | Article | July/August 2015

Left Atrial Appendage Closure With the Watchman Device

A review of trial results and clinical application.

By Jayant Khitha, MD, and Tanvir K. Bajwa, MD

cit | Article | March/April 2026

Pulmonary Embolism Risk Stratification: Progress, Gaps, and the Path Forward

Key developments, lessons learned, where current tools fall short, and what’s in the pipeline.

By Frances Mae West, MD, MSc, FACP; Thomas M. Todoran, MD, MSc; Andrew J. P. Klein, MD; and James Horowitz, MD

Sponsored by Abbott

cit | Article | September/October 2023 Supplement

Introduction

cit | Article | March/April 2025

Advances and Challenges in Aortic Regurgitation

Epidemiologic trends, current guidelines, and future directions.

By Joanna Bartkowiak, MD; Jonas Lanz, MD; Thomas Pilgrim, MD; and Fabien Praz, MD

cit | Article | May/June 2023

Aortic Stenosis Lifetime Management

Current guidelines support a multidisciplinary heart valve team approach.

By Hooman Bakhshi, MD, and Matthew Sherwood, MD, MHS

cit | Article | January/February 2022

TAVR in Bicuspid Aortic Stenosis: Data and Current Limitations

Reviewing the current state of transcatheter aortic valve replacement in the bicuspid aortic valve and what is needed for further validation.

By Siamac Yazdchi, MD, and Hursh Naik, MD, FSCAI

cit | Article | March/April 2018

Trends in European TAVI Practice

Current application of TAVI in Europe.

By Giuliano Costa, MD; Marco Barbanti, MD; and Corrado Tamburino, MD, PhD

cit | Article | July/August 2018

Status of Transcatheter Mitral Valve Replacement

An emerging frontier with unique anatomic, technical, and clinical challenges.

By Nishtha Sodhi, MD, and Alan Zajarias, MD

cit | Article | September/October 2024

Aortic Regurgitation Frontier: Management Options and Future Directions

Epidemiology and pathophysiology considerations for aortic regurgitation, early results and challenges with off-label and dedicated technology, and innovation needs.

By Mohammed Ahmed, MD; Nishath Quader, MD; Marc Sintek, MD; Tsuyoshi Kaneko, MD; and Alan Zajarias, MD

cit | Article | May/June 2019

Transcatheter Mitral Valve Replacement: Current Challenges and Future Perspective

Is transcatheter mitral valve replacement a better solution for mitral regurgitation than transcatheter repair techniques?

By Pavel Overtchouk, MD; Juan F. Granada, MD; and Thomas Modine, MD, PhD, MBA

cit | News | December 10, 2009

Pulmonary Arteriovenous Malformations and Coronary Artery Fistulas

Pulmonary arteriovenous malformations (PAVMs) and coronary artery fistulas (CAFs) are infrequent clinical problems but can potentially cause significant morbidity and mortality.

cit | Article | March/April 2025

TAVR for AR Spotlight: Do We Have a Pacemaker Issue?

Challenges with nondedicated and dedicated devices, uncertain predictors, and long-term implications.

By Hendrik Wienemann, MD


1
2

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button